Ultragenyx CEO talks the company’s path to profitability in developing drugs for rare diseases
Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.
Similar Posts
Suze’s top 5 ‘forever nevers’
Suze Orman counts down the five money mistakes you should never make.
It’s vital to strike the right balance in your portfolio, all-star investor Rich Bernstein suggests
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Futures Now Institutional Investor Hall of Famer Richard Bernstein plots a strategy to weather market uncertainty and risks. 04:34 Mon, Jul 27 20205:56 PM EDT
China seems to think that it is ‘out of the woods’: Professor
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Edmund Phelps of Columbia University says China seems to think that it has solved its problems, and its economy will see a return to “somewhat higher” growth rates. He also says China could “break loose” with a long wave of rapid innovation….
Jim Cramer says it’s time for investors to take some profit in this hot market
CNBC’s Jim Cramer urged investors to look at their portfolios and take some gains on the stocks that have been on recent runs in this bull market. “If you’ve got a huge gain, I’m begging you to take off something, just take it off the table a little bit, even as nobody wants to sell…
Powerball players eye $450M jackpot
Wednesday’s lottery prize will be the largest since last February.
Trump will make a deal with Iran if he gets re-elected, DAMAC chairman says
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email But Hussain Sajwani, chairman of Middle Eastern property development firm DAMAC, says he doesn’t expect President Donald Trump to secure a deal in the Middle East this year. 02:11 Tue, Jan 21 20208:42 AM EST
